Skip to main content
Erschienen in: Journal of Urban Health 2/2006

01.03.2006

The Effect of Hepatitis C Virus Infection on Health-Related Quality of Life in Prisoners

verfasst von: Hla-Hla Thein, Tony Butler, Murray Krahn, William Rawlinson, Michael H. Levy, John M. Kaldor, Gregory J. Dore, MD, MPH, PhD

Erschienen in: Journal of Urban Health | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Hepatitis C virus (HCV) infection in prisoners represents an important public health problem. However, there is very little information about HCV-related health-related quality of life (HRQOL). We examined the effect of HCV antibody positivity, HCV viremia, and being a prisoner on prisoners'' HRQOL. Population-based health surveys incorporating HCV screening were conducted among prisoners at New South Wales (NSW), Australia, correctional centers in 1996 and 2001. HCV antibody and HCV RNA status were determined from venous blood sampling. HRQOL and mood status were assessed using the Short Form-36 (SF-36) Health Survey and Beck Depression Inventory (BDI). Comparison of HRQOL scores between HCV antibody negative, HCV antibody positive/non-viremic, and HCV antibody positive/viremic and assessment of temporal change in HRQOL between 1996 and 2001 within groups were made using ANCOVA adjusting for confounders. Factors associated with HRQOL were determined in linear regression models. Analyses between HCV antibody negative (n = 423), HCV positive/non-viremic (n = 89), and HCV positive/viremic (n = 178) prisoners found no measurable effect of HCV on HRQOL, including that attributable to HCV viremia. Compared to uninfected Australian population norms, prisoners had lower HRQOL irrespective of HCV status. The prevalence of ‘moderate’ to ‘severe’ depressive symptoms was greater in the HCV antibody positive/viremic group than the HCV antibody positive/non-viremic group or the HCV antibody negative group. Selected demographic factors (age), co-morbidity, severity of depressive symptoms and medical care utilization influenced HRQOL. There was evidence to support the effect of knowledge of HCV status on HRQOL. In conclusion, our findings contrast with previous studies in non-prisoner groups in which HCV infection appears to decrease overall HRQOL. Non-HCV factors may override HCV-specific HRQOL impairment in this population. Targeted management strategies are required to improve HRQOL of prisoners.
Literatur
1.
Zurück zum Zitat Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology. 1999;29:264–270.CrossRefPubMed Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology. 1999;29:264–270.CrossRefPubMed
2.
Zurück zum Zitat Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology. 1999;30:550–555.CrossRefPubMed Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology. 1999;30:550–555.CrossRefPubMed
3.
Zurück zum Zitat Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998;27:209–212.CrossRefPubMed Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998;27:209–212.CrossRefPubMed
4.
Zurück zum Zitat Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok AS. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol. 2002;36:401–407.CrossRefPubMed Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok AS. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol. 2002;36:401–407.CrossRefPubMed
5.
Zurück zum Zitat Fontana RJ, Moyer CA, Sonnad S, et al. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol. 2001;96:170–178.CrossRefPubMed Fontana RJ, Moyer CA, Sonnad S, et al. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol. 2001;96:170–178.CrossRefPubMed
6.
Zurück zum Zitat Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol. 2001;96:2737–2744.CrossRefPubMed Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol. 2001;96:2737–2744.CrossRefPubMed
7.
Zurück zum Zitat Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology. 2004;39:74–80.CrossRefPubMed Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology. 2004;39:74–80.CrossRefPubMed
8.
Zurück zum Zitat Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology. 1999;30:1299–1301.CrossRefPubMed Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology. 1999;30:1299–1301.CrossRefPubMed
9.
Zurück zum Zitat McHutchison JG, Ware JE Jr, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol. 2001;34:140–147.CrossRefPubMed McHutchison JG, Ware JE Jr, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol. 2001;34:140–147.CrossRefPubMed
10.
Zurück zum Zitat Butler T, Allnutt S, Cain D, Owens D, Muller C. Mental disorder in the New South Wales prisoner population. Aust N Z J Psychiatry. 2005;39:407–413.CrossRefPubMed Butler T, Allnutt S, Cain D, Owens D, Muller C. Mental disorder in the New South Wales prisoner population. Aust N Z J Psychiatry. 2005;39:407–413.CrossRefPubMed
11.
Zurück zum Zitat Butler T, Milner L. The 2001 Inmate Health Survey. 2003. Sydney: NSW Corrections Health Service. ISBN: 0 7347 3560 X. Butler T, Milner L. The 2001 Inmate Health Survey. 2003. Sydney: NSW Corrections Health Service. ISBN: 0 7347 3560 X.
12.
Zurück zum Zitat Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners—NSW, 1996. Aust N Z J Public Health. 1999;23:377–384.PubMed Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners—NSW, 1996. Aust N Z J Public Health. 1999;23:377–384.PubMed
13.
Zurück zum Zitat Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997;166:127–130.PubMed Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997;166:127–130.PubMed
14.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie RC. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie RC. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.CrossRefPubMed
15.
Zurück zum Zitat Darke S, Ward J, Zador D, Swift G. A scale for estimating the health status of opioid users. Br J Addict. 1991;86:1317–1322.CrossRefPubMed Darke S, Ward J, Zador D, Swift G. A scale for estimating the health status of opioid users. Br J Addict. 1991;86:1317–1322.CrossRefPubMed
16.
Zurück zum Zitat Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.PubMedCrossRef Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.PubMedCrossRef
17.
Zurück zum Zitat Likert R. A technique for the measurement of attitudes. Arch Psych. 1932;140:5–55. Likert R. A technique for the measurement of attitudes. Arch Psych. 1932;140:5–55.
18.
Zurück zum Zitat Ware JE, Konsinski M. SF-36 ® Physical & Mental Health Summary Scales: a Manual for Users of Version 1. 2nd ed. Lincoln, Rhode Island: Quality Metric Incorporated; 2001. Ware JE, Konsinski M. SF-36 ® Physical & Mental Health Summary Scales: a Manual for Users of Version 1. 2nd ed. Lincoln, Rhode Island: Quality Metric Incorporated; 2001.
19.
Zurück zum Zitat Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, New York: Guildford; 1979. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, New York: Guildford; 1979.
20.
Zurück zum Zitat Butler T, Kariminia A, Levy M, Kaldor J. Prisons are a risk for hepatitis C transmission. Eur J Epidemiol. 2004;19:1119–1122.CrossRefPubMed Butler T, Kariminia A, Levy M, Kaldor J. Prisons are a risk for hepatitis C transmission. Eur J Epidemiol. 2004;19:1119–1122.CrossRefPubMed
21.
Zurück zum Zitat Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;16:167–188.CrossRefPubMed Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;16:167–188.CrossRefPubMed
22.
Zurück zum Zitat Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman and Hall; 1991. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman and Hall; 1991.
23.
Zurück zum Zitat Australian Bureau of Statistics (ABS). National Health Survey: SF-36 population norms. Canberra: Australian Government Publishing Service; 1997. Australian Bureau of Statistics (ABS). National Health Survey: SF-36 population norms. Canberra: Australian Government Publishing Service; 1997.
24.
Zurück zum Zitat Howell DC. Statistical Methods for Psychology. 5th ed. California: Thomson Learning; 2002. Howell DC. Statistical Methods for Psychology. 5th ed. California: Thomson Learning; 2002.
25.
Zurück zum Zitat Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Academic; 1988. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Academic; 1988.
26.
Zurück zum Zitat Nunnally JC. Psychometric Theory. New York: McGraw-Hill; 1978. Nunnally JC. Psychometric Theory. New York: McGraw-Hill; 1978.
27.
Zurück zum Zitat Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993.
28.
Zurück zum Zitat Matthews G, Kronborg IJ, Dore GJ. Treatment for hepatitis C virus infection among current injection drug users in Australia. Clin Infect Dis. 2005;40(Suppl 5):S325–S329.CrossRefPubMed Matthews G, Kronborg IJ, Dore GJ. Treatment for hepatitis C virus infection among current injection drug users in Australia. Clin Infect Dis. 2005;40(Suppl 5):S325–S329.CrossRefPubMed
29.
Zurück zum Zitat Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology. 2005;41:790–800.CrossRefPubMed Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology. 2005;41:790–800.CrossRefPubMed
30.
Zurück zum Zitat Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35:433–439.CrossRefPubMed Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35:433–439.CrossRefPubMed
31.
Zurück zum Zitat Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001;358:38–39.CrossRefPubMed Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001;358:38–39.CrossRefPubMed
32.
Zurück zum Zitat Fiala M, Looney DJ, Stins M, et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood–brain barrier. Mol Med. 1997;3:553–564.PubMed Fiala M, Looney DJ, Stins M, et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood–brain barrier. Mol Med. 1997;3:553–564.PubMed
33.
Zurück zum Zitat Forton D, Taylor-Robinson S, Karayiamnis P, Thomas H. Identification of brain-specific quasispecies variants of hepatitis C virus (HCV) consistent with viral replication in the central nervous system. Hepatology. 2000;32(Suppl):269A.CrossRef Forton D, Taylor-Robinson S, Karayiamnis P, Thomas H. Identification of brain-specific quasispecies variants of hepatitis C virus (HCV) consistent with viral replication in the central nervous system. Hepatology. 2000;32(Suppl):269A.CrossRef
34.
Zurück zum Zitat Thomas HC, Torok ME, Forton DM, Taylor-Robinson SD. Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. J Hepatol. 1999;31(Suppl 1):152–159.CrossRefPubMed Thomas HC, Torok ME, Forton DM, Taylor-Robinson SD. Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. J Hepatol. 1999;31(Suppl 1):152–159.CrossRefPubMed
35.
Zurück zum Zitat Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661–674.CrossRefPubMed Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661–674.CrossRefPubMed
36.
Zurück zum Zitat Schwarzinger M, Dewedar S, Rekacewicz C, et al. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology. 2004;40:1434–1441.CrossRefPubMed Schwarzinger M, Dewedar S, Rekacewicz C, et al. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology. 2004;40:1434–1441.CrossRefPubMed
37.
Zurück zum Zitat Cordoba J, Reyes J, Esteban JI, Hernandez JM. Labeling may be an important cause of reduced quality of life in chronic hepatitis C. Am J Gastroenterol. 2003;98:226–227.CrossRefPubMed Cordoba J, Reyes J, Esteban JI, Hernandez JM. Labeling may be an important cause of reduced quality of life in chronic hepatitis C. Am J Gastroenterol. 2003;98:226–227.CrossRefPubMed
38.
Zurück zum Zitat Michelson H, Bolund C, Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res. 2000;9:1093–1104.CrossRefPubMed Michelson H, Bolund C, Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res. 2000;9:1093–1104.CrossRefPubMed
39.
Zurück zum Zitat Mooney M, Hannon F, Barry M, Friel S, Kelleher C. Perceived quality of life and mental health status of Irish female prisoners. Ir Med J. 2002;95:241–243.PubMed Mooney M, Hannon F, Barry M, Friel S, Kelleher C. Perceived quality of life and mental health status of Irish female prisoners. Ir Med J. 2002;95:241–243.PubMed
Metadaten
Titel
The Effect of Hepatitis C Virus Infection on Health-Related Quality of Life in Prisoners
verfasst von
Hla-Hla Thein
Tony Butler
Murray Krahn
William Rawlinson
Michael H. Levy
John M. Kaldor
Gregory J. Dore, MD, MPH, PhD
Publikationsdatum
01.03.2006
Verlag
Springer US
Erschienen in
Journal of Urban Health / Ausgabe 2/2006
Print ISSN: 1099-3460
Elektronische ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-005-9015-4

Weitere Artikel der Ausgabe 2/2006

Journal of Urban Health 2/2006 Zur Ausgabe